14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $21.75 $29.07 Wednesday, 24th Apr 2024 ARWR stock ended at $23.29. This is 2.06% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.71% from a day low at $22.89 to a day high of $23.74.
90 days $21.75 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Sep 23, 2020 $43.51 $45.82 $43.28 $44.64 1 736 044
Sep 22, 2020 $42.25 $44.10 $41.60 $43.80 1 419 762
Sep 21, 2020 $41.67 $43.56 $41.26 $41.71 1 294 300
Sep 18, 2020 $46.47 $46.49 $41.76 $43.10 4 014 432
Sep 17, 2020 $46.36 $48.95 $45.55 $45.75 2 649 485
Sep 16, 2020 $40.05 $53.12 $40.05 $47.43 23 983 977
Sep 15, 2020 $34.48 $34.96 $33.61 $33.80 1 034 394
Sep 14, 2020 $33.86 $34.68 $33.22 $34.04 1 363 475
Sep 11, 2020 $35.53 $35.66 $32.86 $33.21 1 894 678
Sep 10, 2020 $36.32 $37.81 $34.90 $35.20 1 261 785
Sep 09, 2020 $35.77 $36.71 $35.21 $36.14 806 078
Sep 08, 2020 $35.25 $36.80 $34.55 $35.47 1 062 018
Sep 04, 2020 $37.50 $37.98 $34.00 $36.04 1 201 721
Sep 03, 2020 $39.50 $39.61 $36.75 $37.06 1 048 876
Sep 02, 2020 $39.01 $40.06 $37.66 $39.83 1 032 320
Sep 01, 2020 $41.88 $42.74 $38.89 $39.00 1 482 674
Aug 31, 2020 $42.58 $43.64 $42.05 $42.24 921 831
Aug 28, 2020 $42.00 $43.01 $41.52 $41.97 664 364
Aug 27, 2020 $42.62 $42.67 $40.33 $41.84 776 214
Aug 26, 2020 $43.24 $43.83 $42.23 $42.37 529 836
Aug 25, 2020 $42.74 $43.63 $42.17 $43.33 447 291
Aug 24, 2020 $43.33 $43.37 $41.52 $42.86 740 522
Aug 21, 2020 $42.80 $43.31 $42.09 $42.49 696 557
Aug 20, 2020 $44.44 $44.80 $41.98 $43.06 967 402
Aug 19, 2020 $44.83 $45.73 $43.76 $44.97 626 605
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT